Canadian hospitals may have exposed 1,307 patients to hepatitis B and C

Some diabetic patients were potentially exposed during individual insulin training sessions


More than 1,300 diabetic patients were potentially exposed to the diseases to hepatitis B and C during individual insulin training sessions at two Canadian hospitals, according to an article on the Global News website.

Letters have been mailed to 1,307 patients at the Grey Nuns and Misericorida Community Hospitals Diabetes Education Centres, between 2013 and early 2016.

The infection control breach happened with the use of saline-filled demonstration pens and pillows used for practice.

The needles and pens were changed after each use, however the pen’s saline reservoir may not have been changed with every patient and the pillows may have been used by multiple patients.

Read the article.

 



July 6, 2017


Topic Area: Infection Control


Recent Posts

Legionella Detected at Michigan Health Facility

Case follows a similar finding of Legionnaires’ disease in a former patient.


Crystal Spring Tower Opens at Carilion Roanoke Memorial Hospital

The new cardiovascular institute improves access and care across the region.


Hospital Evacuation Highlights Importance of Emergency Preparedness

Berger Hospital was evacuated after smoke was discovered in the basement.


Building a Culture of Infection Prevention

Investing in infection prevention can benefit healthcare organizations and patient outcomes.


Ground Broken on Sanford Health Fargo's Peltier Lodge

The 28,400-square-foot facility will feature spaces to support patients and loved ones during treatment and throughout their outpatient care and monitoring.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.